Begin typing your search above and press return to search.
Geert Wilders
access_time 28 Nov 2023 4:50 AM GMT
Cusat tragedy: Let experience be a lesson
access_time 27 Nov 2023 4:00 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
How long will the ceasefire last?
access_time 25 Nov 2023 5:56 AM GMT
The signal from Silkyara tunnel incident
access_time 24 Nov 2023 5:53 AM GMT
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
access_time 16 Aug 2023 5:46 AM GMT
A Constitution always in the making
access_time 27 Nov 2023 11:43 AM GMT
Debunking myth of Israel’s existence
access_time 23 Oct 2023 7:01 AM GMT
Homechevron_rightWorldchevron_rightVax alone is unlikely...

Vax alone is unlikely to contain Covid infections in UK

Vax alone is unlikely to contain Covid infections in UK

Representational image only

London: Vaccinating all adults in the UK is unlikely to achieve herd immunity and fully contain the virus, a new study suggests as reported by IANS

The modelling study, published in The Lancet Infectious Diseases journal, suggests that the gradual release of control measures, high vaccine uptake and a vaccine with high protection against infection is essential to minimise future waves of infection.

"Our modelling suggests that vaccination rollout in adults alone is unlikely to completely stop Covid-19 cases spreading in the UK," said researcher Matt Keeling, Professor at University of Warwick in the UK.

"We also found that early sudden release of restrictions is likely to lead to a large wave of infection, whereas gradually easing measures over a period of many months could reduce the peak of future waves," Keeling added.

This study modelled the combined interaction of the UK vaccination rollout with different scenarios of relaxing control measures, to predict the R number and deaths and hospital admissions due to Covid-19 from January 2021 to January 2024.

The model assumed vaccine uptake would be 95 per cent in those aged 80 years and older, 85 per cent in those aged 50-79 years, and 75 per cent in those aged 18-49 years, as well as looking at a more optimistic uptake scenario (95 per cent, 90 per cent, and 85 per cent, respectively), and a more pessimistic scenario (90 per cent, 80 per cent, and 70 per cent, respectively).

Vaccine protection against symptomatic disease was assumed to be 88 per cent based on phase 3 trial data from the Pfizer-BioNTech and Oxford-AstraZeneca vaccines being administered in the UK (the analysis was done before early real-world data from vaccination rollout studies).

Since the vaccines' protection against infection is still uncertain, it was varied in four scenarios (0 per cent, 35 per cent, 60 per cent, and 85 per cent).

The findings suggest that although vaccination can substantially reduce Reproduction (R), it may not be enough to drive R below 1 without other control measures. Under the most optimistic scenario for protection against infection (85 per cent), the R number is estimated to be 1.58 without other controls.

Show Full Article
TAGS:UKCOVID19Covid-19 vaccine
Next Story